Acetaminophen; Aspirin; Caffeine Patent Expiration
Acetaminophen; Aspirin; Caffeine is Used for relieving migraine pain and associated symptoms like photophobia, phonophobia, nausea, and functional disability. It was first introduced by Haleon Us Holdings Llc
Acetaminophen; Aspirin; Caffeine Patents
Given below is the list of patents protecting Acetaminophen; Aspirin; Caffeine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Excedrin (migraine Relief) | US5972916 | Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine |
Jul 14, 2017
(Expired) | Haleon Us Holdings |
Acetaminophen; Aspirin; Caffeine's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List